advanced search

INJECTION

TOP FIVE DRUG DELIVERY TRENDS FOR 2021
EXPERT VIEW
Tom Oakley
TOP FIVE DRUG DELIVERY TRENDS FOR 2021
Tom Oakley provides an overview of the top five trends to expect in drug delivery in 2021.
PLATFORM TRAINING SOLUTIONS ADD VALUE FOR PHARMACEUTICAL COMPANIES
INJECTION
Alex Catino
Noble
PLATFORM TRAINING SOLUTIONS ADD VALUE FOR PHARMACEUTICAL COMPANIES
Alex Catino discusses the unmet need in healthcare for proper patient onboarding and training in the field of prefilled syringes and injection devices. Ms Catino uses Noble’s training device for Ypsomed’s YpsoMate® autoinjector as a case study for how bespoke training devices can be used to help improve the patient experience and adherence rates.
TACKLING PARENTERAL DRUG LABELLING’S SURGING COMPLEXITY
EXPERT VIEW
Lars Skole
TACKLING PARENTERAL DRUG LABELLING’S SURGING COMPLEXITY
Lars Skole discusses emerging trends and challenges associated with growing parenteral packaging and labelling complexity – and how pharmaceutical developers and manufacturers can meet the challenges ahead.
INJAY: SIMPLE BY CHOICE, ADAPTABLE BY DESIGN
CONNECTIVITY
Arnaud Guillet
Biocorp
INJAY: SIMPLE BY CHOICE, ADAPTABLE BY DESIGN
Arnaud Guillet discusses Biocorp’s Injay solution for adding connectivity to a wide variety of PFS devices, focusing on how Injay’s designed-in simplicity and flexibility makes it easily applicable across the spectrum of PFS platforms on the market today.
NEW ENGINE FOR PRIMARY CONTAINER INJECTORS: A POWERFUL MICRO LINEAR ACTUATOR
EARLY INSIGHT
Dr Brian Li
MicroMED Co Ltd
NEW ENGINE FOR PRIMARY CONTAINER INJECTORS: A POWERFUL MICRO LINEAR ACTUATOR
Brian Li, Jiunn-Ru Lai, Tsung-Chieh Cheng, Kuang-Hsiang Cheng, Min-Ru Wang, Chia-Chi Tina Feng, and Wen-Chi Huang introduce the company’s new engine for primary container injectors, the Primary Actuator, which targets the unmet needs in the autoinjector and wearable injector market as the market shifts towards large injection volumes.
BUILDING A BETTER PREFILLED SYRINGE FOR COVID-19 VACCINE PACKAGING
PREFILLED SYRINGES
Carina Van Eester
Datwlyer
BUILDING A BETTER PREFILLED SYRINGE FOR COVID-19 VACCINE PACKAGING
Carina Van Eester shares key learnings since the launch of the company’s NeoFlex plungers at the start of the covid-19 pandemic.
STEVANATO & EITAN BRING NEXT-GENERATION WEARABLE DRUG DELIVERY SOLUTIONS TO MARKET
WEARABLES
Chiara Mussoi
Stevanato Group
STEVANATO & EITAN BRING NEXT-GENERATION WEARABLE DRUG DELIVERY SOLUTIONS TO MARKET
Chiara Mussoi, Riccardo Prete and Mindy Katz outline the benefits of collaboration when it comes to bringing wearable drug delivery solutions to market.
AN INCLUSIVE APPROACH TO THE DEVELOPMENT OF PLATFORM MEDICAL DEVICES
PREFILLED SYRINGES
Finola Austin
Owen Mumford
AN INCLUSIVE APPROACH TO THE DEVELOPMENT OF PLATFORM MEDICAL DEVICES
Finola Austin discusses the difficulties presented by designing a user testing programme for platform devices when the target patient population is as yet unknown, and presents the testing framework based on seven user groups that Owen Mumford uses to meet this challenge.
BD HYLOK™ – GLASS PREFILLABLE SYRINGE FOR IV APPLICATIONS
PREFILLED SYRINGES
Sophie Trémeau
BD (Becton Dickinson & Company)
BD HYLOK™ – GLASS PREFILLABLE SYRINGE FOR IV APPLICATIONS
Sophie Trémeau, Maxime Nicolas and Myriam Leszczynski discuss BD Hylok™, a prefillable glass syringe for intravenous applications, including the rigorous testing BD Hylok™ has undergone and the regulatory support BD is able to provide to its pharmaceutical partners.
INNOVATING IN THE VISCOSITY DESIGN SPACE: A NEW 2.25 ML AUTOINJECTOR PLATFORM
INJECTION
Karima Yadi
BD (Becton Dickinson & Company)
INNOVATING IN THE VISCOSITY DESIGN SPACE: A NEW 2.25 ML AUTOINJECTOR PLATFORM
Karima Yadi and Lionel Maritan discuss BD’s response to the need for an autoinjector platform that reconciles the demands of biologics with safety, reliability and ease of use during self-injection: the Intevia™ 2.25 mL disposable autoinjector.
HOW TO KEEP THE GRANDFATHER DILEMMA FROM INTERRUPTING DRUG REDEVELOPMENT
INJECTION
Chris Rojewski
Pfizer CentreOne
HOW TO KEEP THE GRANDFATHER DILEMMA FROM INTERRUPTING DRUG REDEVELOPMENT
Chris Rojewski provides programme insights into approval pathways for the redevelopment of pharmaceutical compounds.
INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING
SUSTAINABILITY
Jiae Kim
Roquette
INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING
Jiae Kim introduces isosorbide, a plant starch-derived diol made from renewable feedstock that has wide ranging applications across polymer materials for a variety of industries.
CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION
EXPERT VIEW
George I’ons
CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION
George I’ons discusses the challenges developing connected devices presents to key market stakeholders when it comes to successful rollout and implementation. Additionally, he considers the perspectives of these market players, as well as the patients themselves, with respect to how connected drug delivery devices can help them to better achieve their desired outcomes.
MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE
CONNECTIVITY
Mr Michael Kiely
Jabil Healthcare
MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE
Michael Kiely, Laura Marsden, Peter Stringer, and David Boyle discuss the design challenges at the electromechanical interface and encourage manufacturers to adopt a standardised approach for connecting medical devices to the cloud.
MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE
CONNECTIVITY
Arnaud Guillet
Biocorp
MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE
Arnaud Guillet reviews the Mallya connected device platform, from the origins of the project to the current success in diabetes and deployment in other fields, and introduces the promising next-generation Mallya.
THE COVID-19 CATALYST: HOW A GLOBAL PANDEMIC IS ACCELERATING THE NEED FOR DIGITAL HEALTH
CONNECTIVITY
Marcus Bates
Aptar Pharma
THE COVID-19 CATALYST: HOW A GLOBAL PANDEMIC IS ACCELERATING THE NEED FOR DIGITAL HEALTH
Marcus Bates discusses the positive impact covid-19 has had on the digital health industry, including the acceleration and development of remote patient services.
D-FLEX<sup>®</sup> ECOSYSTEM – FROM DATA TO VALUE
CONNECTIVITY
Dr Fred Metzmann
Haselmeier
D-FLEX® ECOSYSTEM – FROM DATA TO VALUE
Fred Metzmann and Frank Leipold discuss the benefits of connected medical devices in clinical trials and describe the advantages of Haselmeier's D-Flex® Ecosystem for improving adherence and reducing the dropout rate in clinical trials.
THE NEW EMERGING NEEDS DRIVING AUTOINJECTOR DEVELOPMENT
INJECTION
Dr Iain Simpson
Phillips Medisize
THE NEW EMERGING NEEDS DRIVING AUTOINJECTOR DEVELOPMENT
Iain Simpson discusses the emerging needs to be considered when bringing new autoinjector drug-device combinations to market.
MEASURING & MANAGING MEDICATION ADHERENCE FROM CLINICAL TRIALS TO ROUTINE CARE: INJAY MEMS AS<sup>®</sup>
CONNECTIVITY
Arnaud Guillet
Biocorp
MEASURING & MANAGING MEDICATION ADHERENCE FROM CLINICAL TRIALS TO ROUTINE CARE: INJAY MEMS AS®
Arnaud Guillet and Bernard Vrijens discuss the issue of medication non-adherence in both clinical trials and commercialised drug products, and how Biocorp’s Injay connected prefilled syringe solution combined with Aardex’s MEMS Adherence Software provides a solution.
THE “CUSTOMISABLE PLATFORM” PARADOX
INDUSTRIALISATION
Lyndon Wild
SHL Medical
THE “CUSTOMISABLE PLATFORM” PARADOX
Lyndon Wild and Gene Rhode Fuensalida Pantig present a systematic analysis of the customisable platform architecture found in the Molly® autoinjector technology.
TRAINING DEVICES & PATIENT EDUCATION PLAY A CRUCIAL ROLE IN THE SELF-INJECTION DRUG DELIVERY MARKET
PREFILLED SYRINGES
Joe Reynolds
Noble
TRAINING DEVICES & PATIENT EDUCATION PLAY A CRUCIAL ROLE IN THE SELF-INJECTION DRUG DELIVERY MARKET
Joe Reynolds discusses the role training devices and patient education play with regard to self-injection therapies.
LEVERAGING INTEGRATION THROUGHOUT A DRUG DELIVERY SYSTEM PROJECT
INDUSTRIALISATION
Steven Kaufman
Stevanato Group
LEVERAGING INTEGRATION THROUGHOUT A DRUG DELIVERY SYSTEM PROJECT
Steven Kaufman and Adam Stops describe how an integrated offering can help customers at each phase of a drug delivery system project.
GERRESHEIMER INCLUDES STEVANATO GROUP INTEGRATED TWIST-OFF CLOSURE SYSTEM FOR GX<sup>®</sup> RTF SYRINGES
PREFILLED SYRINGES
Mr Maximilian Vogl
Gerresheimer
GERRESHEIMER INCLUDES STEVANATO GROUP INTEGRATED TWIST-OFF CLOSURE SYSTEM FOR GX® RTF SYRINGES
Maximilian Vogl reveals the latest user-friendly addition to its Gx RTF Luer lock syringes using Stevanto Group’s integrated twist-off closure technology.
VERIFYING THE CONTAINER CLOSURE INTEGRITY OF CUSTOM PRIMARY PACKAGING
PREFILLED SYRINGES
Dr Alex Vasiev
SMC Ltd
VERIFYING THE CONTAINER CLOSURE INTEGRITY OF CUSTOM PRIMARY PACKAGING
Alex Vasiev, Connor Everett and Steven Hay explore the challenges of verifying the container closure integrity of custom primary packaging.
Top